ketamine cystitis
Conditions
Interventions
bladder autoaugmentation by transurethral vesicomyotomy(BATV):performed bladder autoaugmentation by transurethral vesicomyotomy
bladder hydrodistention(BH):performed bladder hydrodistention
Sponsors
Department of Urology, Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Age
12 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. A history of ketamine use; 2.M-receptor antagonists, analgesics, a-receptor agonists, bladder perfusion therapy with hyaluronic acid and other conservative treatment is ineffective; 3. intolerance or unwillingness to undergo urological reconstruction; 4. bladder contracture induced by ketamine; 5. refractory recurrent lower urinary tract symptoms (frequent urination, urgency of urination, dysuria), pelvic pain, and hematuria caused by ketamine cystitis.
Exclusion criteria
Exclusion criteria: 1. Failed tolerance to lithotomy position; 2. Severe cardiopulmonary insufficiency which may induce failed tolerance to surgery; 3. poor compliance or refusal to follow-up periodically and to sign treatment consent and informed consent for research;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bladder capacity;Qmax;PVR;ICSI score;ICPI score;PUF score;VAS score;QoL score;complications;hospital stay;Catheterisation time (d);estimated blood loss (mL);Addiction time (yr); | — |
Countries
China
Contacts
Public ContactTang Zhengyan
Xiangya Hospital of Central South University
Outcome results
None listed